Cancer Drugmaker Parabilis Surges 58% in US Trading Debut

Parabilis Medicines Inc. shares jumped 58% in its trading debut, after the company raised nearly $745 million in an upsized US initial public offering that priced above its marketed range and a private placement.
Source
Bloomberg Markets
Opens original article in a new tab



